Zobrazeno 1 - 10
of 168
pro vyhledávání: '"Briassoulis E"'
Autor:
Bafaloukos, D., Tsoutsos, D., Kalofonos, H., Chalkidou, S., Panagiotou, P., Linardou, E., Briassoulis, E., Efstathiou, E., Polyzos, A., Fountzilas, G., Christodoulou, C., Kouroussis, C., Iconomou, T., Gogas, H. *
Publikováno v:
In Annals of Oncology June 2005 16(6):950-957
Autor:
Skarlos, D.V. *, Samantas, E., Briassoulis, E., Panoussaki, E., Pavlidis, N., Kalofonos, H.P., Kardamakis, D., Tsiakopoulos, E., Kosmidis, P., Tsavdaridis, D., Tzitzikas, J., Tsekeris, P., Kouvatseas, G., Zamboglou, N., Fountzilas, G.
Publikováno v:
In Annals of Oncology September 2001 12(9):1231-1238
Autor:
Joerger, M., Huitema, A. D. R., Richel, D. J., Dittrich, C., Pavlidis, Nicholas, Briassoulis, E. Ch, Vermorken, J. B., Strocchi, E., Martoni, A., Sorio, R., Sleeboom, H. P., Izquierdo, M. A., Jodrell, D. I., Calvert, H., Boddy, A. V., Hollema, H., Féty, R., Vijgh, W. J. F. Van Der, Hempel, G., Chatelut, E., Karlsson, M., Wilkins, J., Tranchand, B., Schrijvers, A. H. G. J., Twelves, C., Beijnen, J. H., Schellens, J. H. M.
Publikováno v:
Clinical Cancer Research, 13(21), 6410-6418. AMER ASSOC CANCER RESEARCH
Clinical cancer research, 13(21), 6410-6418. American Association for Cancer Research Inc.
Clinical Cancer Research
Clinical cancer research
Clinical cancer research, 13(21), 6410-6418. American Association for Cancer Research Inc.
Clinical Cancer Research
Clinical cancer research
Purpose: Paclitaxel and carboplatin are frequently used in advanced ovarian cancer following cytoreductive surgery. Threshold models have been used to predict paclitaxel pharmacokinetic-pharmacodynamics, whereas the time above paclitaxel plasma conce
Autor:
Briassoulis, E. Ch, Karavasilis, V., Tzamakou, E., Piperidou, C., Soulti, K., Pavlidis, Nicholas
Publikováno v:
Anti-Cancer Drugs
The aim of this study is to investigate the feasibility and determine the pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunction. This was a prospective study. Patients with liver metastases who had either transami
Autor:
Karavasilis, V., Malamou-Mitsi, Vassiliki D., Briassoulis, E. Ch, Tsanou, E., Kitsou, E., Pavlidis, Nicholas
Publikováno v:
International Journal of Gynecological Cancer
The aim of the study was to investigate angiogenesis in patients with advanced-stage ovarian carcinoma. We used paraffin-embedded tumor tissues from 33 patients diagnosed with FIGO III ovarian cancer who had optimal surgery and received platinum-base
Autor:
Briassoulis, E. Ch, Samantas, E., Kalofonos, H. P., Skarlos, Dimosthenis V., Makatsoris, T., Christodoulou, C., Fountzilas, George, Bamias, A. T., Dimopoulos, M. A., Kosmidis, Paraskevas A., Pavlidis, Nicholas
Publikováno v:
Cancer chemotherapy and pharmacology
AIM: The irinotecan-cisplatin combination has emerged as a new standard for the treatment of advanced-stage small-cell lung cancer (AS-SCLC). To move forward we developed a 3-day regimen of cisplatin, etoposide and irinotecan. METHODS: Successive coh
Autor:
Pentheroudakis, George, Briassoulis, E. Ch, Karavasilis, V., Mauri, D., Tzamakou, E., Rammou, D., Pavlidis, Nicholas
Publikováno v:
Chemotherapy
Purpose: We performed a phase I study of two fixed dosing schemes of cisplatin, a DNA cross-linker, with intravenous escalating topotecan, a DNA-topoisomerase I inhibitor. Experimental Design: 40 patients with advanced solid tumors received intraveno
Autor:
Briassoulis, E. Ch, Karavasilis, V., Tzamakou, E., Rammou, D., Soulti, K., Piperidou, C., Pavlidis, Nicholas
Publikováno v:
Cancer chemotherapy and pharmacology
Purpose: To investigate the pharmacokinetics of polyethylene glycol-coated liposomal doxorubicin (PLD, Caelyx) when given as a single agent and in combination with the taxanes paclitaxel or docetaxel in humans. Methods: The plasma kinetics of PLD wer
Autor:
Fountzilas, George, Papadimitriou, C., Dafni, U., Bafaloukos, Dimitrios, Skarlos, Dimosthenis V., Moulopoulos, L. A., Razi, E. D., Kalofonos, H. P., Aravantinos, Gerasimos, Briassoulis, E. Ch, Papakostas, P., Abela, K., Gogas, H., Kosmidis, Paraskevas A., Pavlidis, Nicholas, Dimopoulos, M. A.
Publikováno v:
Scopus-Elsevier
Journal of Clinical Oncology
Journal of Clinical Oncology
PURPOSE: To compare the efficacy of two different schedules of epirubicin and paclitaxel, as first-line chemotherapy, in patients with advanced breast cancer (ABC). PATIENTS AND METHODS: From October 1997 until May 1999, 183 eligible patients with AB
Autor:
Razi, E. D., Dimopoulos, M. A., Bafaloukos, Dimitrios, Papadimitriou, C., Kalogera-Fountzila, Anna, Kalofonos, H. P., Briassoulis, E. Ch, Samantas, E., Keramopoulos, A., Pavlidis, Nicholas, Kosmidis, Paraskevas A., Fountzilas, George
Publikováno v:
Cancer investigation
The purpose of this study was to evaluate the activity and toxicity profile of dose-dense sequential chemotherapy with epirubicin (EPI) and paclitaxel in advanced breast cancer (ABC). From January to September 1997, 41 patients with recurrent or meta